1. Use of Nanoselenium in Chemotherapy Drug Delivery Systems
    I. A. Shurygina et al, 2020, Nanotechnologies in Russia CrossRef
  2. JNK signaling pathway regulates the development of ovaries and synthesis of vitellogenin (Vg) in the swimming crab Portunus trituberculatus
    Hongling Wei et al, 2020, Cell Stress and Chaperones CrossRef
  3. Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma
    Yong Xiao et al, 2021, Bioscience Reports CrossRef
  4. Selenium nanostructure: Progress towards green synthesis and functionalization for biomedicine
    V. R. Ranjitha et al, 2021, Journal of Pharmaceutical Investigation CrossRef
  5. Anisomycin inhibits angiogenesis, growth, and survival of triple-negative breast cancer through mitochondrial dysfunction, AMPK activation, and mTOR inhibition
    Wenjuan Yang et al, 2022, Canadian Journal of Physiology and Pharmacology CrossRef
  6. microRNA let-7c is essential for the anisomycin-elicited apoptosis in Jurkat T cells by linking JNK1/2 to AP-1/STAT1/STAT3 signaling
    Zhiwei Zhou et al, 2016, Scientific Reports CrossRef
  7. The effects of silibin administration for different time periods on mouse liver with Ehrlich ascites carcinoma
    Alisa Bahar Beydogan et al, 2016, Pharmacological Reports CrossRef
  8. Antibiotic anisomycin selectively targets leukemia cell lines and patient samples through suppressing Wnt/β-catenin signaling
    Yong Li et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  9. Novel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro
    Yu Xia et al, 2015, Nanoscale Research Letters CrossRef
  10. Antibacterial and antitumor activities of 3-amino-phenyl-4(3H)-quinazolinone/polypyrrole chitosan core shell nanoparticles
    Nehal Salahuddin et al, 2017, Polymer Bulletin CrossRef
  11. Anisomycin sensitizes non‐small‐cell lung cancer cells to chemotherapeutic agents and epidermal growth factor receptor inhibitor via suppressing PI3K/Akt/mTOR
    Hongxia Tan et al, 2021, Fundamental & Clinical Pharmacology CrossRef